Potassium Chloride Oral SolutionPronunciation
Dosage Form: oral solution
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Potassium Chloride Oral Solution, USP
citric acid, D&C Red #33, FD&C Red #40, glycerin, purified water, sodium benzoate, sodium saccharin, sorbitol solution, wild cherry flavor.
For treatment of patient with hypokalemia, with or without metabolic alkalosis, in digitalis intoxication.
To minimize gastrointestinal irritation, patients must follow direction regarding dilution. Each tablespoonful (15mL) should be diluted with three (3) fluid ounce or more of water or other liquid.
USUAL ADULT DOSE
One (1) tablespoonful (15mL) twice daily (after morning or evening meals) supplies 40 mEq of potassium.
Discontinue immediately if abdominal pain, distension, nausea, vomiting or gastrointestinal bleeding occurs. CONTRAINDICATED in the presence of dehydration or impaired kidney function. Potassium intoxication causes electrocardiographic abnormalities, flaccid paralysis of the skeletal muscles, paresthesias of the extremeties, listlessness, mental confusion, weakness and heaviness of the legs, fall in blood pressure, cardiac arrhythmias. Frequent checks of the clinical status of the patient, and periodic ECG and/or serum potassium levels should be made. Potassium intensifies the symptoms of myotonia congenita.
Interaction with Potassium Sparing Diuretics: Hypokalemia should not be treated by the concomitant administration of potassium salts and potassium-sparing diuretics (e.g., spironolactone, triamterene or amiloride) since the simultaneous administration of these agents can produce severe hyperkalemia. Interaction with ACE inhibitors: Angiotensin converting enzyme (ACE) inhibitors (e.g., captopril, enlapril) will produce some potassium retention by inhibiting aldosterone production. Potassium supplements should be given to patients receiving ACE inhibitors only with close monitoring.
Hyperkalemia, when detected, must be treated immediately because lethal levels can be reached in a few hours.
Dispense in tight, light-resistant container as defined in USP/NF.
Store at 20 - 25°C (66 to 77°F). Avoid Freezing.
Adverse Drug Event: Call (866) 562-4597
PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label
Oral Solution, USP
10% Cherry Flavored
40 m Eq. Potassium per 30mL
Replacement therapy for
To be used for oral administration only.
TAMPER-EVIDENT: Do not use this product
if inner foil seal over the mouth of the
bottle is cut, torn, broken or missing.
Bio-Pharm, Incorporated Levittown, PA 19057
PACK Pharmaceuticals, LLC Buffalo Grove, IL 60089
ONE PINT (473 mL)
potassium chloride liquid
|Labeler - Pack Pharmaceuticals LLC (614823875)|
|Bio-Pharm, Inc.||801652546||MANUFACTURE(16571-303), ANALYSIS(16571-303), PACK(16571-303), LABEL(16571-303)|
More about potassium chloride
- Potassium Chloride (FDA)
- Potassium Chloride Capsules (FDA)
- Potassium Chloride Injection (FDA)
- Potassium Chloride Injection Concentrate (FDA)
- Potassium Chloride Powder for Oral Solution (FDA)